Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05161195 |
| Title | Roll-over Study to Allow Continued Access to Ribociclib |
| Recruitment | Recruiting |
| Gender | both |
| Phase | FDA approved |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | TUR | POL | LBN | ITA | GRC | ESP | BRA | ARG |